These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Alarcón-Segovia D; Alarcón-Riquelme ME; Cardiel MH; Caeiro F; Massardo L; Villa AR; Pons-Estel BA; Arthritis Rheum; 2005 Apr; 52(4):1138-47. PubMed ID: 15818688 [TBL] [Abstract][Full Text] [Related]
69. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation. Carreño LJ; Riedel CA; Kalergis AM Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620 [TBL] [Abstract][Full Text] [Related]
70. Immune Responses at Host Barriers and Their Importance in Systemic Autoimmune Diseases. Schinnerling K; Penny HA; Soto JA; Melo-Gonzalez F Adv Exp Med Biol; 2023; 1408():3-24. PubMed ID: 37093419 [TBL] [Abstract][Full Text] [Related]
71. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542 [TBL] [Abstract][Full Text] [Related]
73. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484 [TBL] [Abstract][Full Text] [Related]
74. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases. Blanco LP; Kaplan MJ PLoS Biol; 2023 Apr; 21(4):e3002084. PubMed ID: 37098006 [TBL] [Abstract][Full Text] [Related]
75. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)]. Kiss M; Husz S; Dobozy A Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350 [TBL] [Abstract][Full Text] [Related]
76. Bridging autoantibodies and arthritis: the role of Fc receptors. el Bannoudi H; Ioan-Facsinay A; Toes RE Curr Top Microbiol Immunol; 2014; 382():303-19. PubMed ID: 25116106 [TBL] [Abstract][Full Text] [Related]
77. Fc gamma receptor biology and systemic lupus erythematosus. Jovanovic V; Dai X; Lim YT; Kemeny DM; MacAry PA Int J Rheum Dis; 2009 Dec; 12(4):293-8. PubMed ID: 20374365 [TBL] [Abstract][Full Text] [Related]
78. Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus. Annable T; Tomassian T; Jain S; Leibbrandt M; Cooke MP; Deane JA Autoimmunity; 2015 Feb; 48(1):29-39. PubMed ID: 25483245 [TBL] [Abstract][Full Text] [Related]
79. [Correlation research on the expression of FcgammaR II b on B cells and rheumatoid arthritis patients of Shen deficiency syndrome]. Liao QH; Guo LK; Luo SZ; Lai RG; Liu XL; Chen GX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1203-7. PubMed ID: 24273974 [TBL] [Abstract][Full Text] [Related]
80. Novel molecular targets for systemic lupus erythematosus. Marino M; Rossi M; Ruvo M; Fassina G Curr Drug Targets; 2002 Jun; 3(3):223-8. PubMed ID: 12041736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]